0 584

Cited 32 times in

Pulmonary Vein Isolation Alone Versus Additional Linear Ablation in Patients With Persistent Atrial Fibrillation Converted to Paroxysmal Type With Antiarrhythmic Drug Therapy: A Multicenter, Prospective, Randomized Study

DC Field Value Language
dc.contributor.author김태훈-
dc.contributor.author박희남-
dc.contributor.author엄재선-
dc.contributor.author유희태-
dc.contributor.author이문형-
dc.contributor.author정보영-
dc.date.accessioned2018-07-20T07:34:51Z-
dc.date.available2018-07-20T07:34:51Z-
dc.date.issued2017-
dc.identifier.issn1941-3149-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/160309-
dc.description.abstractBACKGROUND: Atrial fibrillation (AF) type can vary depending on condition and timing, and some patients who initially present with persistent AF may be changed to paroxysmal AF after antiarrhythmic drug medication and cardioversion. We investigated whether circumferential pulmonary vein isolation (CPVI) alone is an effective rhythm control strategy in patients with persistent AF to paroxysmal AF. METHODS AND RESULTS: We enrolled 113 patients with persistent AF to paroxysmal AF (male 75%, 60.4±10.1 years old) who underwent catheter ablation for nonvalvular AF at 3 tertiary hospitals. The participants were randomly assigned to 2 groups: CPVI alone (n=59) or CPVI plus linear ablation (CPVI+Line; posterior box+anterior line, n=54). Compared with the CPVI+Line, CPVI alone required shorter procedure (187.2±58.0 versus 211.2±63.9 min; P=0.043) and ablation times (4922.1±1110.5 versus 6205.7±1425.2 s; P<0.001) without difference in procedure-related major complication (3% versus 2%; P=0.611). Antiarrhythmic drug utility rates after ablation were not different between the 2 groups (22% versus 30%; P=0.356). Overall, AF-free survival (log-rank; P=0.206) and AF and antiarrhythmic drug-free survival (log-rank; P=0.321) were not different between groups. CONCLUSIONS: CPVI alone is an effective rhythm control strategy with a shorter procedure time in persistent AF patients converted to paroxysmal AF compared with CPVI with linear ablation.-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherLippincott Williams & Wilkins-
dc.relation.isPartOfCIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAction Potentials-
dc.subject.MESHAged-
dc.subject.MESHAnti-Arrhythmia Agents/adverse effects-
dc.subject.MESHAnti-Arrhythmia Agents/therapeutic use*-
dc.subject.MESHAtrial Fibrillation/diagnosis-
dc.subject.MESHAtrial Fibrillation/physiopathology-
dc.subject.MESHAtrial Fibrillation/surgery*-
dc.subject.MESHCatheter Ablation/adverse effects-
dc.subject.MESHCatheter Ablation/methods*-
dc.subject.MESHDisease-Free Survival-
dc.subject.MESHFemale-
dc.subject.MESHHeart Rate-
dc.subject.MESHHumans-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHOperative Time-
dc.subject.MESHProspective Studies-
dc.subject.MESHPulmonary Veins/physiopathology-
dc.subject.MESHPulmonary Veins/surgery*-
dc.subject.MESHSeoul Tertiary Care Centers-
dc.subject.MESHTime Factors-
dc.subject.MESHTreatment Outcome-
dc.titlePulmonary Vein Isolation Alone Versus Additional Linear Ablation in Patients With Persistent Atrial Fibrillation Converted to Paroxysmal Type With Antiarrhythmic Drug Therapy: A Multicenter, Prospective, Randomized Study-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine-
dc.contributor.departmentDept. of Internal Medicine-
dc.contributor.googleauthorHee Tae Yu-
dc.contributor.googleauthorJaemin Shim-
dc.contributor.googleauthorJunbeom Park-
dc.contributor.googleauthorIn-Soo Kim-
dc.contributor.googleauthorTae-Hoon Kim-
dc.contributor.googleauthorJae-Sun Uhm-
dc.contributor.googleauthorBoyoung Joung-
dc.contributor.googleauthorMoon-Hyoung Lee-
dc.contributor.googleauthorYoung-Hoon Kim-
dc.contributor.googleauthorHui-Nam Pak-
dc.identifier.doi10.1161/CIRCEP.116.004915-
dc.contributor.localIdA01085-
dc.contributor.localIdA01776-
dc.contributor.localIdA02337-
dc.contributor.localIdA02535-
dc.contributor.localIdA02766-
dc.contributor.localIdA03609-
dc.contributor.localIdA00840-
dc.relation.journalcodeJ00537-
dc.identifier.eissn1941-3084-
dc.identifier.pmid28611206-
dc.identifier.urlhttp://circep.ahajournals.org/content/10/6/e004915.long-
dc.subject.keywordantiarrhythmic drug-
dc.subject.keywordatrial fibrillation-
dc.subject.keywordcatheter ablation-
dc.subject.keywordpersistent atrial fibrillation-
dc.subject.keywordrecurrent event-
dc.contributor.alternativeNameKim, Tae Hoon-
dc.contributor.alternativeNamePak, Hui Nam-
dc.contributor.alternativeNameUhm, Jae Sun-
dc.contributor.alternativeNameYu, Hee Tae-
dc.contributor.alternativeNameLee, Moon Hyoung-
dc.contributor.alternativeNameJoung, Bo Young-
dc.contributor.affiliatedAuthorKim, Tae-Hoon-
dc.contributor.affiliatedAuthorPak, Hui Nam-
dc.contributor.affiliatedAuthorUhm, Jae Sun-
dc.contributor.affiliatedAuthorYu, Hee Tae-
dc.contributor.affiliatedAuthorLee, Moon Hyoung-
dc.contributor.affiliatedAuthorJoung, Bo Young-
dc.citation.volume10-
dc.citation.number6-
dc.citation.startPagee004915-
dc.identifier.bibliographicCitationCIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, Vol.10(6) : e004915, 2017-
dc.identifier.rimsid40971-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.